Aya Sugimoto Selected Research

Aya Sugimoto Research Topics

Disease

8	Neoplasms (Cancer) 03/2024 - 09/2018
4	Carcinoma (Carcinomatosis) 11/2023 - 04/2016
3	Stomach Neoplasms (Stomach Cancer) 11/2019 - 01/2019
2	Intestinal Volvulus (Volvulus) 04/2024 - 12/2020
2	Ulcerative Colitis 01/2024 - 02/2022
2	Diverticulitis 12/2022 - 01/2019
2	Diverticular Diseases 10/2022 - 01/2019
2	Malignant Mesothelioma 06/2022 - 11/2020
2	Lung Neoplasms (Lung Cancer) 02/2022 - 02/2020
2	Hepatitis 05/2021 - 12/2017
1	Endometriosis 03/2024
1	Carcinogenesis 03/2024
1	Cysts 03/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024
1	Chemical and Drug Induced Liver Injury 01/2024
1	Colorectal Neoplasms (Colorectal Cancer) 04/2023
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 02/2023
1	Disease Progression 02/2023
1	Portal Hypertension 02/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Hemorrhage 10/2022
1	Adenocarcinoma of Lung 06/2022
1	Drug-Related Side Effects and Adverse Reactions 02/2022
1	Colitis 02/2022
1	Adenocarcinoma 08/2021
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2021
1	Hyperbilirubinemia 05/2021
1	Necrosis 05/2021
1	Immunoglobulin G4-Related Disease 05/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2020
1	Blister (Bulla) 01/2020
1	Hypertension (High Blood Pressure) 01/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Polyps 07/2018
1	Neoplasm Metastasis (Metastasis) 06/2018
1	Melanoma (Melanoma, Malignant) 06/2018
1	Hepatolenticular Degeneration (Wilson's Disease) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Hepatitis B 12/2017
1	Infections 12/2017
1	Lymphoma (Lymphomas) 12/2017
1	Arthralgia (Joint Pain) 01/2017
1	Pancreatitis 12/2016

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 02/2020
3	RNA (Ribonucleic Acid)IBA 06/2022 - 02/2020
2	Mesalamine (Mesalazine)FDA LinkGeneric 01/2024 - 02/2022
2	MicroRNAs (MicroRNA)IBA 11/2023 - 09/2018
2	Warfarin (Coumadin)FDA LinkGeneric 04/2023 - 10/2022
2	AnticoagulantsIBA 10/2022 - 01/2019
2	NivolumabIBA 02/2022 - 06/2018
2	Biomarkers (Surrogate Marker)IBA 08/2021 - 12/2017
2	Indicators and Reagents (Reagents)IBA 02/2020 - 07/2018
2	Proton Pump InhibitorsIBA 01/2020 - 01/2019
1	IronIBA 03/2024
1	Small Interfering RNA (siRNA)IBA 11/2023
1	Transcription Factors (Transcription Factor)IBA 11/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 10/2022
1	Fixatives (Pickling Agents)IBA 06/2022
1	Nucleic AcidsIBA 06/2022
1	Immune Checkpoint InhibitorsIBA 02/2022
1	AcidsIBA 02/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2021
1	Bevacizumab (Avastin)FDA Link 08/2021
1	Imatinib Mesylate (Gleevec)FDA Link 06/2021
1	Transaminases (Aminotransferases)IBA 05/2021
1	Antinuclear AntibodiesIBA 05/2021
1	Immunoglobulins (Immunoglobulin)IBA 05/2021
1	MucinsIBA 11/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2020
1	Epidermal Growth Factor (EGF)IBA 11/2020
1	Formaldehyde (Formol)FDA Link 02/2020
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2020
1	TabletsIBA 01/2020
1	Lansoprazole (Prevacid)FDA LinkGeneric 01/2020
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 01/2020
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2020
1	Rabeprazole (Aciphex)FDA Link 01/2020
1	LaxativesIBA 01/2019
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2019
1	LipidsIBA 01/2019
1	Interferon-betaIBA 06/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2018
1	Alanine Transaminase (SGPT)IBA 06/2018
1	CopperIBA 01/2018
1	Penicillamine (Cuprimine)FDA Link 01/2018
1	Ceruloplasmin (Ferroxidase)IBA 01/2018
1	Zinc Acetate FDA Link 01/2018
1	Glucosamine (Dona)IBA 01/2017
1	Amylases FDA Link 12/2016

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 02/2024 - 12/2017
6	Therapeutics 04/2024 - 10/2014
1	Decompression 04/2024
1	Length of Stay 10/2022
1	Sclerotherapy 12/2020
1	Treatment Delay 01/2019
1	Aftercare (After-Treatment) 06/2018